OR WAIT 15 SECS
© 2021 MJH Life Sciences and Pharmaceutical Executive. All rights reserved.
© 2021 MJH Life Sciences™ and Pharmaceutical Executive. All rights reserved.
January 12, 2021
Embracing the new, holistic views of pharma in 2021.
January 05, 2021
Mike Hennessey Sr., Chairman and Founder of MJH Life Sciences, pushes for the celebration of the pharmaceutical industry after nine grueling months of fighting COVID-19.
October 14, 2020
Previewing executive trends thought of by leaders in the pharma industry.
September 16, 2020
In this September 2020 Product Launch issue of Pharm Exec, we highlight five products, all approved in 2019, and showcase what is now their early brand journey.
September 10, 2020
Multicultural campaigns crafted for diverse populations are insufficiently funded and do not receive the same support as mainstream campaigns, writes Sheila Thorne. While there are plenty of people willing to partner with pharma on these campaigns, will the industry wake up to the changing world ahead?
August 24, 2020
COVID-19 has only magnified well known flaws of our healthcare system. An extension of Medicare is the affordable solution, writes Bruno Delagneau, and pharma needs to start planning for this to minimize its impact on US revenues.
August 18, 2020
Dr. Manuel Hermosilla shares his thoughts on how the pharmaceutical industry reacts to challenges that arise during trials, specifically during the search for an effective COVID-19 vaccine.
August 10, 2020
How “Contractual Genericization” could revitalize pharma and reframe the public conversation.
July 09, 2020
Gilead's pricing of COVID drug remdesivir is a reminder of pharma's tenuous path forward as it seeks a more holistic image makeover.
June 01, 2020
While scientists are striving to discover and produce safe and effective vaccines to halt the coronovirus outbreak, anti-vacciners are revving up misinformation campaigns.